Cargando…
Financial burden associated with discordance to intravenous iron therapies in US patients with iron deficiency anemia
BACKGROUND: Iron deficiency anemia (IDA) affects approximately 5 million people in the United States and has a significant impact on human health. Intravenous (IV) iron is indicated for treatment of IDA when oral iron is not effective or not tolerated. Several IV iron products are available, includi...
Autores principales: | Polson, Michael K, Bahrain, Huzefa, Ogden, Jonathan F, Utkina, Karina, Bucco, Ryan A, Khan, Nabeel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394207/ https://www.ncbi.nlm.nih.gov/pubmed/37133430 http://dx.doi.org/10.18553/jmcp.2023.22407 |
Ejemplares similares
-
Ferumoxytol for the treatment of iron deficiency and iron-deficiency
anemia of pregnancy
por: Gerb, Jesse, et al.
Publicado: (2021) -
Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
por: Wesström, Jan
Publicado: (2020) -
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
por: Froessler, Bernd, et al.
Publicado: (2018) -
Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations
por: Koch, Todd A., et al.
Publicado: (2015) -
Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011)